ATR vs WST
ATR: AptarGroup is a global leader in drug delivery and consumer product dispensing solutions, providing specialized pumps, valves, and packaging for pharmaceutical and consumer goods markets. WST: West Pharmaceutical Services provides essential high-quality, sterile packaging and delivery systems for injectable medications globally.
Side-by-side fundamentals
| Metric | ATR | WST | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $121.81 | $363.27 | |
| Market cap | $7.7B | $25.6B | |
| P/E as of 2026-10-08 | 22.01 | 46.44 | ATR lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 1.23 | n/a | |
| Net margin FY2025, SEC XBRL | +10.4% | +16.1% | WST higher |
| Gross margin FY2025, SEC XBRL | n/a | +35.9% | |
| Operating margin FY2025, SEC XBRL | +13.3% | +19.0% | WST higher |
| ROE FY2025, SEC XBRL | +14.6% | +15.5% | WST higher |
| ROA FY2025, SEC XBRL | +7.5% | +11.6% | WST higher |
| Debt / equity as of 2026-09-03 | 0.52 | 0.07 | WST lower |
| Revenue growth (YoY) as of 2026-09-03 | +8.9% | +12.4% | WST higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | +2.1% | ATR higher |
| Dividend yield as of 2026-09-03 | +1.5% | +0.2% | ATR higher |
| Dividend streak (yrs) SEC XBRL | 7 | 15 | WST higher |
| Beta as of 2026-09-03 | 0.59 | 0.59 | |
| 1-year return as of 2026-10-08 close | -7.4% | +35.6% | WST higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.